文献速递免疫规划传染病防控与疫情报告

轮状病毒疫苗对以色列全因急性胃肠炎及轮状病毒胃肠炎住院的影响:一项全国性分析

Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
PubMed 文献 · Vaccine · 2020-02-03

以色列于2010年12月将五价轮状病毒疫苗(RotaTeq)纳入国家免疫规划。该全国性分析显示,0-59月龄儿童全因急性胃肠炎住院率在普种疫苗年份较接种前下降38.7%-53.0%,轮状病毒胃肠炎住院率在2016-2017年下降89.1%。中断时间序列分析显示普种轮状病毒免疫对两类住院率下降有显著影响。

要点

  • 普种轮状病毒疫苗后,0-59月龄儿童全因急性胃肠炎住院率较接种前下降38.7%-53.0%。
  • 轮状病毒胃肠炎住院率在2016-2017年较接种前下降89.1%。
  • 阿拉伯儿童全因急性胃肠炎住院率下降幅度低于犹太儿童,但两组轮状病毒胃肠炎住院率下降相似。

核心结论

  • 全国住院数据显示,实施轮状病毒疫苗普种规划后,全因急性胃肠炎和轮状病毒胃肠炎住院率均出现大幅且持续的下降。

研究设计与样本

  • 研究提取以色列全国医院出院数据库数据,计算0-59月龄儿童全因急性胃肠炎和轮状病毒胃肠炎年住院率,比较接种前年份(2002-2008)与普种疫苗年份(2011-2017)的平均住院率,并进行中断时间序列分析。
  • 2008-2010年间轮状病毒疫苗为部分可及。

主要发现

  • 共报告131,116例急性胃肠炎住院,其中13,111例(10.0%)编码为轮状病毒胃肠炎住院。
  • 接种前时期全因急性胃肠炎年均住院率为147.9(95%CI 146.7-149.0)/10,000名0-59月龄儿童,普种疫苗年份下降38.7%-53.0%。
  • 接种前轮状病毒胃肠炎年均住院率为16.9(95%CI 16.5-17.3)/10,000名儿童,2016-2017年下降89.1%。
  • 中断时间序列分析显示,引入轮状病毒疫苗普种对全因急性胃肠炎和轮状病毒胃肠炎住院率下降有显著影响。
  • 多变量自回归积分滑动平均模型显示,变量「免疫时期」是普种疫苗年份轮状病毒胃肠炎住院的显著预测因子(t=7.3,p<0.001)。

关键数值与推荐

  • 全因急性胃肠炎住院率下降幅度:38.7%-53.0%(普种疫苗年份较接种前)。
  • 轮状病毒胃肠炎住院率下降幅度:89.1%(2016-2017年较接种前)。
  • 轮状病毒胃肠炎住院率预测模型:免疫时期 t=7.3,p<0.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In December 2010, the pentavalent rotavirus vaccine (RotaTeq) was added to the national immunization program in Israel. The study aim was to examine national reductions in all-cause acute gastroenteritis (AGE) and rotavirus gastroenteritis (RVGE) hospitalizations among children aged 0-59 months following the introduction of universal rotavirus immunization in Israel. METHODS: We extracted data from the Israel National Hospital Discharge Database. Hospitalization rates were calculated by dividing the annual number of all-cause AGE and RVGE hospitalizations by the number of children aged 0-59 months residing Israel. To assess rate reductions, we compared the mean hospitalization rate for the pre-vaccine years (2002-2008) with that for the universal vaccination years (2011-2017). Interrupted time-series analyses were undertaken. During 2008-2010 rotavirus vaccines were partially available. RESULTS: A total of 131,116 AGE hospitalizations were reported, of which 13,111 (10.0%) were coded as RVGE hospitalizations. The average annual all-cause AGE hospitalization rate during the pre-vaccine period was 147.9 (95% CI 146.7-149.0) per 10,000 children aged 0-59 months, and declined by 38.7-53.0% during the universal vaccination years. The average annual pre-vaccine RVGE hospitalization rate was 16.9 (95% CI 16.5-17.3) per 10,000 children, and declined by 89.1% during 2016-2017. Findings from interrupted time-series analyses showed significant impact of introducing universal rotavirus immunization on the declines of all-cause AGE and RVGE hospitalizations rates. A multivariable Autoregressive Integrated Moving Average model showed that the variable "immunization period" was a significant predictor of RVGE hospitalizations (t = 7.3, p < 0.001) for the universal vaccination years. The declines in hospitalizations rates of all-cause AGE were lower among Arab children compared to Jewish children, but the declines in RVGE rates were similar between the groups. CONCLUSIONS: National hospitalization data demonstrated substantial and consistent reductions in all-cause AGE and RVGE hospitalizations following the implementation of universal rotavirus vaccination program.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Muhsen K, Haklai Z, Applbaum Y, et al. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis. Vaccine. 2020. PMID: 32029322. doi:10.1016/j.vaccine.2020.01.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。